Anatara Lifesciences Ltd (ANR.AX) Investor Presentation

Brisbane, Australia (ABN Newswire) - Anatara Lifesciences (ASX:ANR) releases the presentation which Chief Executive Officer, Mr Steven Lydeamore, will present to investors in Perth this week and to the Gold Coast Investment Showcase later this month.

This presentation had been largely prepared prior to last week's announcement that animal health company, Zoetis had made a portfolio decision not to continue with the pursuit of Anatara's lead animal health asset, Detach(R). To that end, while a new slide has been incorporated to reflect the current state of affairs with Detach(R), this presentation does not reflect the new commercialisation strategy for Detach(R), which Anatara's Board and Management team is closely reviewing over the coming weeks.

CEO, Steve Lydeamore commented, "We have been working hard this year to communicate with investors as transparently as possible regarding our progress. Continuing with our planned presentations in Perth and the Gold Coast this month is in keeping with our desire to communicate openly.

While the Board does not have all the answers regarding the future of the Detach(R) program at this stage, we are focused on determining the next steps in a timely manner and will communicate those as soon as practical in the coming weeks. In the meantime, we look forward to engaging with investors to discuss what we currently know and discuss the work we're doing in the area of human gastrointestinal health through our dietary supplement program."

Any shareholders with questions regarding Anatara's recent announcements or the attached investor presentation are invited to contact the company using the contact info below. Those investors wishing to attend the Gold Coast Investment Showcase are invited to register for complementary attendance via this link: http://www.abnnewswire.net/lnk/MQ2A70M6

To view the investor presentation, please visit:
http://abnnewswire.net/lnk/5DLIP935

About Anatara Lifesciences Ltd:

Anatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

Source:

Anatara Lifesciences Ltd

Contact:

Investor inquiries

Mr Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: [email protected]

Media inquiries

Jane Lowe
Managing Director, IR Department
T: +61-411-117-774
E: [email protected]